Integra LifeSciences Corporation   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Plainsboro NJ United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2010
NCT01108263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Integra | Integra LifeSciences | Integra LifeSciences Corporation | Integra Medical Inc.

Active Ingredients

Drugs in Phase 4 Trials (1)

collagen (1 trial)

Drugs in Phase 3 Trials (4)

Key: Integra LifeSciences Corporation (1) Acquired (3)

acetylsalicylic acid (aspirin) (1 trial)

aclerastide (4 trials)

clopidogrel (plavix) (1 trial)

placental tissue extract (1 trial)

Drugs in Phase 2 Trials (1)

autologous microbiome (1 trial)

Drugs in Other Trials (3)

Key: Integra LifeSciences Corporation (0) Acquired (3)

collagenase clostridium histolyticum (xiaflex) (1 trial)

leptospermum honey (2 trials)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 4)

Foot Ulcer (Phase 4)

Gingivitis (Phase 2)

Inflammation (Phase 2)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 9